Infiltrating urothelial carcinoma
MONDO:0040678A invasive carcinoma that involves the urothelium.
Also known as: infiltrating transitional cell carcinoma of the urinary tract, infiltrating urothelial carcinoma
2952 clinical trials for this condition and its sub-types, 5 tagged with Infiltrating urothelial carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Infiltrating urothelial carcinoma
-
Infiltrating bladder urothelial carcinoma 183 trials · 185 incl. sub-types
9 sub-types
- Infiltrating bladder urothelial carcinoma sarcomatoid variant 5 trials
- Plasmacytoid variant infiltrating bladder urothelial carcinoma 4 trials
- Micropapillary variant infiltrating bladder urothelial carcinoma 3 trials
- Infiltrating bladder lymphoepithelioma-like carcinoma 1 trial
- Nested variant infiltrating bladder urothelial carcinoma 1 trial
- Infiltrating bladder urothelial carcinoma, clear cell variant 0 trials
- Lipid-cell variant infiltrating bladder urothelial carcinoma 0 trials
- Lymphoma-like variant infiltrating bladder urothelial carcinoma 0 trials
- Microcystic variant infiltrating bladder urothelial carcinoma 0 trials
-
2 sub-types
-
Personalized vaccine + immunotherapy aims to stop bladder cancer return
Disease control OngoingThis phase 2 trial tests whether adding a personalized cancer vaccine (autogene cevumeran) to the immunotherapy drug nivolumab can prevent high-risk bladder cancer from coming back after surgery. About 62 participants will receive either the combination or nivolumab alone. The st…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Real-World data sought on nivolumab for bladder cancer after surgery
Knowledge-focused OngoingThis study observes 400 Japanese patients with muscle-invasive urothelial carcinoma who received nivolumab after surgery to remove their cancer. Researchers will track how long patients stay cancer-free, side effects, and how the drug is actually used in clinics. The goal is to s…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC